DK0585896T3 - Lægemiddel til topisk applikation i øjenområdet til behandling af forhøjet intraokulært tryk - Google Patents

Lægemiddel til topisk applikation i øjenområdet til behandling af forhøjet intraokulært tryk

Info

Publication number
DK0585896T3
DK0585896T3 DK93113966.1T DK93113966T DK0585896T3 DK 0585896 T3 DK0585896 T3 DK 0585896T3 DK 93113966 T DK93113966 T DK 93113966T DK 0585896 T3 DK0585896 T3 DK 0585896T3
Authority
DK
Denmark
Prior art keywords
intraocular pressure
topical application
elevated intraocular
eye area
application drug
Prior art date
Application number
DK93113966.1T
Other languages
Danish (da)
English (en)
Inventor
Helmut Dr Franz
Hannes Edgar Kompa
Tibor Prof Dr Rozman
Original Assignee
Basotherm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basotherm Gmbh filed Critical Basotherm Gmbh
Application granted granted Critical
Publication of DK0585896T3 publication Critical patent/DK0585896T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK93113966.1T 1992-09-04 1993-09-01 Lægemiddel til topisk applikation i øjenområdet til behandling af forhøjet intraokulært tryk DK0585896T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4229494A DE4229494A1 (de) 1992-09-04 1992-09-04 Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks

Publications (1)

Publication Number Publication Date
DK0585896T3 true DK0585896T3 (da) 1997-04-14

Family

ID=6467184

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93113966.1T DK0585896T3 (da) 1992-09-04 1993-09-01 Lægemiddel til topisk applikation i øjenområdet til behandling af forhøjet intraokulært tryk

Country Status (19)

Country Link
US (1) US5527831A (cs)
EP (1) EP0585896B1 (cs)
JP (1) JPH06172158A (cs)
KR (1) KR940006575A (cs)
CN (1) CN1086132A (cs)
AT (1) ATE145823T1 (cs)
AU (1) AU673533B2 (cs)
CA (1) CA2105530A1 (cs)
CZ (1) CZ284095B6 (cs)
DE (2) DE4229494A1 (cs)
DK (1) DK0585896T3 (cs)
ES (1) ES2096161T3 (cs)
GR (1) GR3022225T3 (cs)
HU (1) HU213272B (cs)
NO (1) NO933140L (cs)
NZ (1) NZ248567A (cs)
PL (1) PL300286A1 (cs)
SK (1) SK79893A3 (cs)
ZA (1) ZA936504B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716819B2 (en) * 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
AR034200A1 (es) 2001-01-12 2004-02-04 Novartis Ag Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
JP2005035969A (ja) * 2003-06-25 2005-02-10 Lion Corp 眼科用組成物及び該組成物の安定化方法
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
US9911989B2 (en) * 2005-07-25 2018-03-06 Bloom Energy Corporation Fuel cell system with partial recycling of anode exhaust
DK2148667T3 (da) * 2007-04-12 2013-08-26 Waratah Pharmaceuticals Inc Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
CA2858574C (en) 2011-12-07 2017-05-30 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
KR102487299B1 (ko) 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
ITUB20153104A1 (it) * 2015-08-13 2017-02-13 Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) * 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
IL62447A (en) * 1980-03-21 1983-11-30 Wellcome Found Stabilized ophthalmic formulations
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
DE3700379A1 (de) * 1987-01-08 1988-07-21 Mann Gerhard Chem Pharm Fab Konservierte augentropfen mit einem gehalt an cromoglicinsaeure
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.

Also Published As

Publication number Publication date
CZ284095B6 (cs) 1998-08-12
ZA936504B (en) 1995-03-03
NO933140L (no) 1994-03-07
CA2105530A1 (en) 1994-03-05
NO933140D0 (no) 1993-09-03
DE4229494A1 (de) 1994-03-10
AU673533B2 (en) 1996-11-14
ES2096161T3 (es) 1997-03-01
GR3022225T3 (en) 1997-04-30
HU9302502D0 (en) 1993-11-29
NZ248567A (en) 1995-11-27
CN1086132A (zh) 1994-05-04
ATE145823T1 (de) 1996-12-15
US5527831A (en) 1996-06-18
JPH06172158A (ja) 1994-06-21
DE59304658D1 (de) 1997-01-16
PL300286A1 (en) 1994-03-07
EP0585896B1 (de) 1996-12-04
SK79893A3 (en) 1994-08-10
CZ181193A3 (en) 1994-07-13
KR940006575A (ko) 1994-04-25
HUT64836A (en) 1994-03-28
EP0585896A1 (de) 1994-03-09
HU213272B (en) 1997-04-28
AU4610593A (en) 1994-03-10

Similar Documents

Publication Publication Date Title
DK0585896T3 (da) Lægemiddel til topisk applikation i øjenområdet til behandling af forhøjet intraokulært tryk
BRPI0413381A (pt) composições para liberação de compostos terapêuticos nos olhos e processos para fabricação e uso das mesmas
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
NO975962D0 (no) Legemiddelpreparat som omfatter albumin som aktiv bestanddel
ES2042625T3 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
AR011192A1 (es) Composiciones oftalmicas que comprenden una prostaglandina y el uso de los mismos en la preparacion de un medicamento para tratar glaucoma
ES2032390T3 (es) Composicion antihipertensiva ocular para uso topico. (reserva del art. 167.2 cpe).
BR0116466A (pt) Lentes de contato dinamicamente estabilizadas
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
EP0045617A3 (en) Pharmaceutical composition
ES2127375T3 (es) Procedimiento de administracion de un farmaco oftalmico.
DK0572190T3 (da) Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens
ES2141736T3 (es) Gel, especialmente para uso terapeutico ocular.
DE69022314D1 (de) Stabile emulgierte Tretinoin-Cremeformulierungen.
DE69829062D1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
ITMI920979A0 (it) N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
ES2179044T3 (es) Compuestos de argatroban para utilizacion oftalmologica.
FI892963A0 (fi) Farmaceutisk sammansaettning samt foerfarande foer dess framstaellning.
DK0447325T5 (da) Ascorbinsyrederivater
LEE et al. A Case of Endophthalmitis after Laser in situ Keratomi leusisLASIK
HA Megalo-bleb phenomenon
IT1241928B (it) Composizione oftalmica per l'uso nel mantenimento della midriasi oculare
KOOK et al. Efficacy and Safety of Subconjunctivally Injected 5-fluorouracil after Mitomycin C Trabeculectomy in High Risk Patients
EP0826371A4 (en) PREPARATION OF EMEDASTIN FOR EXTERNAL USE